Uji klinis Glioma di Arizona
8 studi untuk Glioma mencari peserta di lokasi di Arizona.
Kota di Arizona
Teks studi resmi (Bahasa Inggris)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Banner Children's at Desert, Mesa
Menerima pesertaFase 1/2
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
- Mayo Clinic in Arizona, Phoenix
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05030298SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Arizona, Phoenix
- St. Joseph's Hospital and Medical Center, Phoenix
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Honor Health, Scottsdale
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06910306Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
- Mayo Clinic in Arizona, Phoenix
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06482905Mapping of Electrical Properties in the Brain
- Mayo Clinic in Arizona, Scottsdale
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT06470711A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Chandler Regional Medical Center, Chandler
- St. Joseph's Hospital and Medical Center, Phoenix
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Nov 2025 · NCT06072586Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.